Guideline / position statementindependent cross-checkabstract checked★ key study I-ABX-106 in-depth review

US guideline: gonorrhoea is cured with one antibiotic injection

Sexually Transmitted Infections Treatment Guidelines, 2021.

Overview

Workowski KA et al.. MMWR Recomm Rep 2021 · PMID 34292926 · DOI 10.15585/mmwr.rr7004a1

A single ceftriaxone injection cures more than 99% of genital gonorrhoea; untreated infection can cause infertility.

Does the study support the specific claim? No · Methodological quality: high

Study explained simply

What did the researchers want to find out?: Set US treatment standards for STIs
How was the study done?: National guideline
How many people, animals or samples were studied?: Not applicable
What was actually found?: Single-dose ceftriaxone cures gonorrhoea
How large was the observed effect?: >99% cure
What do the results mean in everyday life?: Gonorrhoea needs testing and antibiotic treatment
What are the study's limitations?: US context; resistance varies
What does it say about Elawady's specific claim?: Contradicts curing gonorrhoea by diet
Do the results apply to Germany and Europe?: High
What can explicitly not be concluded from this study?: Local resistance in Egypt (not covered)

Authors: Workowski KA et al.
Journal: MMWR Recomm Rep
Year: 2021
Identifier: PMID 34292926 DOI 10.15585/mmwr.rr7004a1
Verification: verified – PubMed efetch 2026-10-26 + Crossref
Retracted: no
Corrections: ErratumIn MMWR 2023;72(4):107-108 (PubMed); erratum content not reviewed; no retraction
Extent checked: abstract only
Conflicts of interest and funding: Authors' disclosures listed; several with industry relationships (PubMed COI).

How should sexually transmitted infections, including gonorrhoea, be treated?

Study design: Guideline / position statement – National clinical practice guideline (CDC)
Population: Adolescents and adults with or at risk of STIs
Country: USA
Period: 2021
Sample size: not applicable
Inclusion and exclusion criteria: Expert consultation and evidence review

Results: Gonorrhoea section (full-text sections read): recommended regimen for uncomplicated urogenital/rectal gonorrhoea is ceftriaxone 500 mg IM single dose (1 g if >=150 kg), plus doxycycline if chlamydia not excluded; 'a single injection of ceftriaxone 250 mg is >99% (95% CI 97.6%-99.7%) effective in curing anogenital gonorrhea'. 'Among women, gonococcal infections are commonly asymptomatic or might not produce recognizable symptoms until complications (e.g., PID) have occurred. PID can result in tubal scarring that can lead to infertility or ectopic pregnancy.' Men: symptoms often lead to treatment 'but often not soon enough to prevent transmission to others'.
Absolute risks: Cure >99% with single-dose ceftriaxone (250 mg data)
Authors' conclusion: Gonorrhoea should be treated with ceftriaxone; partners should be evaluated and treated.

Orienting tool: none applicable
Type of assessment: simplified assessment (abstract only)
Full formal assessment: no
Overall risk of bias: not assessable
Rationale: Guideline; relevant sections of full text read (not entire document).

Defines the standard of care and the complications of untreated infection.

None.

High; European guidance is similar (antibiotic treatment, partner notification).

Gonorrhoea is reliably cured by a single antibiotic dose; untreated infection can cause PID, infertility and ectopic pregnancy.

Multidimensional assessment
Multidimensional assessment
Authenticity of the source	verified
Methodological quality	high
Risk of bias	not assessable
Precision of results	not applicable
Directness	direct
Reproducibility	replicated
Consistency with the overall evidence	consistent
Regional transferability	high
Adequacy of the interpretation (by the archive)	not applicable

None for this claim.